Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(A)-binding proteins (PABPs) are highly conserved, multifunctional RNA-binding proteins in eukaryotic cells that bind specifically to the poly(A) tail at the 3’ end of most cytoplasmic mRNAs. They play key roles in almost every step of mRNA metabolism, including polyadenylation, mRNA export, translation initiation (by interacting with the eukaryotic initiation factor 4G and other proteins), mRNA surveillance, stability, and decay. Cytoplasmic PABPs (e.g., PABPC1) collaborate with translation initiation complexes to regulate protein synthesis, while nuclear PABPs (e.g., PABPN1) assist in mRNA processing and export in the nucleus. Their proper function is essential for normal cell viability and development, and although they can be involved in disease states (such as responses to viral infection and some cancers), they are not conventional therapeutic targets. The term "Poly-binding protein" is vague and should be clarified to specific Poly(A)-binding protein family members for accurate context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(A)-binding protein (PABP).